Chinese Journal of Integrative Medicine

, Volume 25, Issue 1, pp 31–36 | Cite as

Garlicin Post-Conditioning Suppresses Adhesion Molecules in a Porcine Model of Myocardial Ischemia-Reperfusion Injury

  • Peng Yang
  • Jia-hui Li
  • Ai-li Li
  • Jing Li
  • Yong Wang
  • Shi-yan Ren
  • Xian-lun LiEmail author
Original Article



To evaluate whether garlicin post-conditioning can attenuate myocardial ischemiareperfusion injury in a catheter-based porcine model of acute myocardial infarction (AMI) by affecting adhesion molecules integrin β1/CD29 and platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31).


Twenty-two swine were devided into 3 groups: 6 in a sham-operation group, and 8 each in the model and garlicin groups. AMI porcine model was established in the model and garlicin groups. The distal parts of the left anterior descending coronary artery in the animals of the model and garlicin groups were occluded by dilated balloon for 2 h, followed by reperfusion for 3 h. Garlicin (1.88 mg/kg) was injected over a period of 1 h, beginning just before reperfusion, in the garlicin group. Real-time polymerase chain reaction, immunohistochemistry and Western blot were carried out to detect mRNA and protein expressions of CD29 and CD31 3 h after reperfusion.


Hematoxylin-eosin staining showed a better myocardial structure in the garlicin group after reperfusion. Compared to the model group, garlicin inhibited both the mRNA and protein expression of CD29 and CD31 in reperfusion area and no-reflflow area (P<0.05 respectively).


Garlicin post-conditioning induced cardio-protection against myocardial ischemia-reperfusion injury in this catheter-based porcine model of AMI. The cardio-protective effect of garlicin is possibly owing to suppression of production of CD29 and CD31, by inhibition of the mRNA expression of CD29 and CD31.


garlicin reperfusion injury myocardial infarction CD29 CD31 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hausenloy D J. Cardiopro tection techniques: preconditioning, postconditioning and remote conditioning. Curr Pham Des 2013;19:4544–4563.CrossRefGoogle Scholar
  2. 2.
    Predmore BL, Kondo K, Bhushan S, Zlatopolsky MA, King AL, Aragon JP, et al. The polysulfide diallyltrisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 2012;302:H2410–H2418.CrossRefGoogle Scholar
  3. 3.
    Peyman M, Surush M, Milad M, Shahin A, Shadi S. Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iran J Basic Med Sci 2013;10:1031–1048.Google Scholar
  4. 4.
    Varshney R, Budoff MJ. Garlic and heart disease. J Nutr 2016;146(Suppl):416S–21S.CrossRefGoogle Scholar
  5. 5.
    Khatua TN, Adela R, Banerjee SK. Garlic and cardioprotection: insights into the molecular mechanisms. Can J Physiol Pharmacol 2013;91:448–458.CrossRefGoogle Scholar
  6. 6.
    Bradley JM, Organ CL, Lefer DJ. Garlic-derived organic polysulfides and myocardial protection. J Nutr 2016;146(Suppl):403S–409S.CrossRefGoogle Scholar
  7. 7.
    Sharma AK, Munajjam A, Vaishnav B, Sharma R, Sharma A, Kishore K, et al. Involvement of adenosine and standardization of aqueous extract of garlic (Allium sativum Linn.) on cardioprotective and cardiodepressant properties in ischemic preconditioning and myocardial ischemia-reperfusion induced cardiac injury. J Biomed Res 2012;26:24–36.CrossRefGoogle Scholar
  8. 8.
    Li JH, Yang P, Li AL, Wang Y, Shi ZX, Ke YN, et al. The preventive effect of garlicin on a porcine model of myocardial infarction reperfusion no-reflow. Chin J Integr Med 2014;20:425–429.CrossRefGoogle Scholar
  9. 9.
    Yang P, Li JH, Li AL, Wang Y, Shi ZX, Ke YN, et al. Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction. Artif Cells Blood Substit Immobil Biotechnol 2012;40:285–289.CrossRefGoogle Scholar
  10. 10.
    Suzuki Y, Lyons JK, Yeung AC, Ikeno F. In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheteriz Cardiovasc Interv 2008;71:100–107.CrossRefGoogle Scholar
  11. 11.
    Haverslag R, Pasterkamp G, Hoefer IE. Targeting adhesion molecules in cardiovascular disorders. Cardiovasc Hematol Disord Drug Targets 2008;8:252–260.CrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine 2017

Authors and Affiliations

  • Peng Yang
    • 1
  • Jia-hui Li
    • 1
  • Ai-li Li
    • 1
  • Jing Li
    • 1
  • Yong Wang
    • 1
  • Shi-yan Ren
    • 1
  • Xian-lun Li
    • 1
    Email author
  1. 1.Department of CardiologyChina-Japan Friendship HospitalBeijingChina

Personalised recommendations